Home Cart 0 Sign in  
X

[ CAS No. 5263-87-6 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 5263-87-6
Chemical Structure| 5263-87-6
Chemical Structure| 5263-87-6
Structure of 5263-87-6 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 5263-87-6 ]

Related Doc. of [ 5263-87-6 ]

Alternatived Products of [ 5263-87-6 ]

Product Details of [ 5263-87-6 ]

CAS No. :5263-87-6 MDL No. :MFCD00006800
Formula : C10H9NO Boiling Point : -
Linear Structure Formula :- InChI Key :HFDLDPJYCIEXJP-UHFFFAOYSA-N
M.W : 159.18 Pubchem ID :14860
Synonyms :
p-Quinanisole

Calculated chemistry of [ 5263-87-6 ]

Physicochemical Properties

Num. heavy atoms : 12
Num. arom. heavy atoms : 10
Fraction Csp3 : 0.1
Num. rotatable bonds : 1
Num. H-bond acceptors : 2.0
Num. H-bond donors : 0.0
Molar Refractivity : 48.24
TPSA : 22.12 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -5.71 cm/s

Lipophilicity

Log Po/w (iLOGP) : 2.05
Log Po/w (XLOGP3) : 2.2
Log Po/w (WLOGP) : 2.24
Log Po/w (MLOGP) : 1.49
Log Po/w (SILICOS-IT) : 2.46
Consensus Log Po/w : 2.09

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -2.76
Solubility : 0.274 mg/ml ; 0.00172 mol/l
Class : Soluble
Log S (Ali) : -2.3
Solubility : 0.8 mg/ml ; 0.00503 mol/l
Class : Soluble
Log S (SILICOS-IT) : -3.82
Solubility : 0.0243 mg/ml ; 0.000153 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.13

Safety of [ 5263-87-6 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 5263-87-6 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 5263-87-6 ]
  • Downstream synthetic route of [ 5263-87-6 ]

[ 5263-87-6 ] Synthesis Path-Upstream   1~14

  • 1
  • [ 5263-87-6 ]
  • [ 577967-89-6 ]
Reference: [1] Patent: WO2012/48181, 2012, A1,
[2] Patent: WO2012/83165, 2012, A1,
  • 2
  • [ 5263-87-6 ]
  • [ 13676-02-3 ]
Reference: [1] Patent: WO2012/48181, 2012, A1,
[2] Patent: WO2012/83165, 2012, A1,
[3] Heterocycles, 2015, vol. 91, # 7, p. 1445 - 1454
[4] European Journal of Organic Chemistry, 2016, vol. 2016, # 8, p. 1606 - 1611
  • 3
  • [ 5263-87-6 ]
  • [ 3373-00-0 ]
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2006, vol. 16, # 13, p. 3415 - 3418
[2] Journal of the Chemical Society, Perkin Transactions 1: Organic and Bio-Organic Chemistry (1972-1999), 1980, p. 1933 - 1939
[3] Patent: EP3293177, 2018, A1,
  • 4
  • [ 5263-87-6 ]
  • [ 120-15-0 ]
YieldReaction ConditionsOperation in experiment
92% With tetrahydroxydiboron; copper diacetate In acetonitrile at 40℃; for 8 h; Schlenk technique General procedure: A 20 mL Schlenk tube was charged with quinoline (1a; 65 mg,0.5 mmol), Cu(OAc)2 (4.5 mg, 0.025 mmol), B2(OH)4 (135 mg,1.5 mmol), and MeCN (2.0 mL). The mixture was stirred at 40 °C for 8 h until the reaction was completed (TLC), then cooled to room temperature and concentrated under reduced pressure. Water (10 mL) was added and the mixture was extracted with EtOAc (3 x 10 mL). The organic phases were combined, dried over anhydrous Na2SO4, filtered, and concentrated under reduced pressure. The residue was purified by column chromatography with petroleum ether/ethyl acetate (8:1) as an eluent to give a brown liquid (2a: 65 mg, 98percent yield).
90% With tetrahydroxydiboron; copper diacetate In acetonitrile at 40℃; for 12 h; 6-methoxyquinoline (0.3 mmol, 48 mg),Tetrahydroxy diboron (0.9mmol, 81mg),Cu (OAc) 2 (0.015 mmol, 2.5 mg) was added to 1 mL of acetonitrile,40 ° C for 12 hours,The residue was purified by thin layer chromatography to give 44.0 mg of 6-methoxytetrahydroquinoline in 90percent yield, 98percent purity,
90% With iron(II) triflate; C13H21N3O2 In chloroform at 40℃; for 2 h; Schlenk technique General procedure: In a 10 mL Schlenk tube, Fe(OTf)2 (0.005 mmol, 1.8 mg), quinoline (0.5 mmol, 72 mg), Hantzsch ester A(1.25 mmol, 318 mg), and 1.0 mL CHCl3were added. The mixture was stirred at 40oCfor 2 h. The solution was concentrated under reduced pressure. The crude product was purified by silica gel column chromatography to afford the pure 1,2,3,4-tetrahydroquinoline (63.8 mg, 96percent yield).
87%
Stage #1: With nickel-aluminum alloy In ethanol at 0 - 4℃; for 0.5 h;
Stage #2: With sodium hydroxide In ethanol; water at 20℃; for 6 h;
To the stirred solution of 6-methoxyquinoline 1 (5 g,31.44 mmol) in ethanol, Ni-Al alloy (2.5 g) was added and stirringwas continued for 30 min. Further, reaction mass was cooled to 0–4 C and then aqueous sodium hydroxide solution (10percent w/v, 50 ml)was added slowly. After the complete addition, reaction mixturewas further stirred at room temperature for 6 h. After completionof reaction as per TLC, reaction mass was passed through a tightcelite bed, further ethanol (2 75 ml) was passed through thecelite bed. Combined filtrate was evaporated on rotary evaporatortill its volume remained one-fourth to its original volume. Further,reaction mass was acidified with 2 N HCl, until its pH became neutral.Further, reaction mass was taken in separating funnel andextracted twice with ethyl acetate (2 150 ml). Combined ethylacetate layer was first washed with water (300 ml) and then withbrine (300 ml). Ethyl acetate layer was dried over anhydroussodium sulphate and finally evaporated on rotary evaporator toafford the compound 2 as crude oil. Crude 2 was purified by columnchromatography using 5percent ethyl acetate in hexane as mobilephase and silica (mesh size 100–200) as stationary phase, whichafforded the pure compound 2, as light yellow oil with 87percent yield[33].
85% With iodine; 4,4,5,5-tetramethyl-[1,3,2]-dioxaboralane In dichloromethane at 20℃; for 24 h; The elemental iodine (0.05 mmol) and 6-methoxy-quinoline (0.25 mmol) were added to the reaction flask to displace the air.Dichloromethane (1 mL) and pinacol borane (1 mmol) were added separately;After stirring at room temperature for 24 hours,The reaction mixture was diluted with dichloromethane (5 mL).The combined organic layers were dried over anhydrous sodium sulfate, filtered and evaporated.The crude product was separated by column chromatography (ethyl acetate: petroleum ether 1percent to 10percent).6-methoxy-tetrahydroquinoline, colorless oil,The yield was 85percent.
39% With platinum(IV) oxide; hydrogen In methanol at 45℃; for 24 h; 6-Methoxyquinoline (3.0 g, 18.85 mmol) and PtO2 (0.2 g 0.8 mmol) were dissolved in methanol (20 mL) andheated to 45 °C and stirred for 24 hours. The reaction was detected by TLC. After the reaction was cooled to roomtemperature, the residue was isolated by silica gel column chromatography (petroleum ether/ethyl acetate = 10: 1) toobtain a compound 26A (pale yellow oil, 1.2 g, the yield was 39percent) after spin-drying the solvent.1H NMR (400 MHz, CHLOROFORM-d) d 6.51-6.66 (m, 2H), 6.45 (d, J = 8.5 Hz, 1H), 3.73 (s, 3H), 3.20-3.30 (m, 2H),2.76 (t, J = 6.5 Hz, 2H), 1.86-1.98 (m, 2H).

Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2006, vol. 16, # 13, p. 3415 - 3418
[2] Advanced Synthesis and Catalysis, 2017, vol. 359, # 4, p. 677 - 686
[3] Advanced Synthesis and Catalysis, 2017, vol. 359, # 6, p. 933 - 940
[4] Chemistry - A European Journal, 2016, vol. 22, # 48, p. 17151 - 17155
[5] ChemCatChem, 2017, vol. 9, # 13, p. 2496 - 2505
[6] Chemical Science, 2018, vol. 9, # 42, p. 8134 - 8141
[7] Tetrahedron Letters, 1987, vol. 28, # 1, p. 77 - 80
[8] Bulletin of the Chemical Society of Japan, 1989, vol. 62, # 9, p. 2968 - 2976
[9] Tetrahedron Letters, 2016, vol. 57, # 3, p. 329 - 332
[10] Tetrahedron, 2018, vol. 74, # 17, p. 2121 - 2129
[11] Angewandte Chemie - International Edition, 2017, vol. 56, # 12, p. 3216 - 3220[12] Angew. Chem., 2017, vol. 129, # 12, p. 3264 - 3268,5
[13] Patent: CN106831565, 2017, A, . Location in patent: Paragraph 0095; 0096; 0097; 0098
[14] Tetrahedron Letters, 2017, vol. 58, # 36, p. 3571 - 3573
[15] ACS Catalysis, 2018, vol. 8, # 5, p. 4545 - 4557
[16] Chemistry - A European Journal, 2018,
[17] Tetrahedron, 1996, vol. 52, # 5, p. 1631 - 1636
[18] Chemistry Letters, 2010, vol. 39, # 8, p. 832 - 834
[19] Bioorganic Chemistry, 2016, vol. 67, p. 75 - 83
[20] Journal of the American Chemical Society, 2015, vol. 137, # 36, p. 11718 - 11724
[21] Journal of Medicinal Chemistry, 2010, vol. 53, # 17, p. 6490 - 6505
[22] Chemical Communications, 2018, vol. 54, # 62, p. 8622 - 8625
[23] Patent: CN108822030, 2018, A, . Location in patent: Paragraph 0031; 0032; 0033; 0034
[24] Advanced Synthesis and Catalysis, 2015, vol. 357, # 4, p. 753 - 760
[25] Advanced Synthesis and Catalysis, 2016, vol. 358, # 19, p. 3039 - 3045
[26] ChemCatChem, 2013, vol. 5, # 8, p. 2183 - 2186
[27] Catalysis Science and Technology, 2017, vol. 7, # 10, p. 1981 - 1985
[28] Synthetic Communications, 1998, vol. 28, # 3, p. 485 - 492
[29] Chemical Communications, 2017, vol. 53, # 66, p. 9262 - 9264
[30] Catalysis Science and Technology, 2018, vol. 8, # 10, p. 2648 - 2653
[31] Synthetic Communications, 1990, vol. 20, # 22, p. 3553 - 3562
[32] Chemistry - A European Journal, 2012, vol. 18, # 2, p. 574 - 585
[33] Bioorganic and Medicinal Chemistry, 2009, vol. 17, # 2, p. 830 - 847
[34] Synlett, 1998, # 9, p. 1029 - 1030
[35] Journal of the Chemical Society. Perkin Transactions 1, 2001, # 9, p. 955 - 977
[36] Patent: EP3293177, 2018, A1, . Location in patent: Paragraph 0222; 0223
[37] Monatshefte fuer Chemie, 1885, vol. 6, p. 767
[38] Fortschr. Teerfarbenfabr. Verw. Industriezweige, vol. 1, p. 180
[39] Journal of the American Chemical Society, 1944, vol. 66, p. 401
[40] Journal of Organic Chemistry, 1946, vol. 11, p. 175
[41] Journal of the Chemical Society, Perkin Transactions 1: Organic and Bio-Organic Chemistry (1972-1999), 1980, p. 1933 - 1939
[42] Helvetica Chimica Acta, 1985, vol. 68, p. 1952 - 1960
[43] Journal of the American Chemical Society, [44] Journal of the American Chemical Society, 2009, vol. 131, p. 8410 - 8412
[45] Patent: US2006/58361, 2006, A1, . Location in patent: Page/Page column 35-36
[46] Bioorganic and Medicinal Chemistry, 2012, vol. 20, # 21, p. 6313 - 6320
[47] Journal of the American Chemical Society, 2012, vol. 134, # 42, p. 17592 - 17598,7
[48] Organic and Biomolecular Chemistry, 2013, vol. 11, # 7, p. 1209 - 1215
[49] Catalysis Science and Technology, 2015, vol. 5, # 10, p. 4746 - 4749
[50] Journal of Materials Chemistry A, 2017, vol. 5, # 7, p. 3260 - 3266
[51] Chemical Science, 2017, vol. 8, # 12, p. 8164 - 8169
[52] Tetrahedron Letters, 2018, vol. 59, # 10, p. 949 - 953
[53] Organic Letters, 2018, vol. 20, # 4, p. 1171 - 1174
[54] Molecular Catalysis, 2018, vol. 452, p. 145 - 153
[55] Applied Catalysis A: General, 2018, vol. 560, p. 37 - 41
[56] Angewandte Chemie - International Edition, 2018, vol. 57, # 31, p. 9950 - 9954[57] Angew. Chem., 2018, vol. 130, p. 10098 - 10102,5
  • 5
  • [ 5263-87-6 ]
  • [ 120-15-0 ]
Reference: [1] Green Chemistry, 2017, vol. 19, # 3, p. 749 - 756
  • 6
  • [ 5263-87-6 ]
  • [ 67-63-0 ]
  • [ 120-15-0 ]
Reference: [1] Tetrahedron Letters, 2004, vol. 45, # 16, p. 3215 - 3217
  • 7
  • [ 5263-87-6 ]
  • [ 120-15-0 ]
  • [ 75414-06-1 ]
Reference: [1] Journal of the American Chemical Society, 2016, vol. 138, # 37, p. 12234 - 12242
  • 8
  • [ 5263-87-6 ]
  • [ 120-15-0 ]
Reference: [1] Chemical Communications, 2015, vol. 51, # 35, p. 7558 - 7561
  • 9
  • [ 5263-87-6 ]
  • [ 10500-57-9 ]
  • [ 120-15-0 ]
  • [ 75414-06-1 ]
Reference: [1] Journal of the Chemical Society, Perkin Transactions 1: Organic and Bio-Organic Chemistry (1972-1999), 1980, p. 1933 - 1939
  • 10
  • [ 5263-87-6 ]
  • [ 64-18-6 ]
  • [ 120-15-0 ]
  • [ 1013-36-1 ]
Reference: [1] Advanced Synthesis and Catalysis, 2017, vol. 359, # 4, p. 677 - 686
  • 11
  • [ 5263-87-6 ]
  • [ 105532-25-0 ]
Reference: [1] Monatshefte fuer Chemie, 1885, vol. 6, p. 767
  • 12
  • [ 5263-87-6 ]
  • [ 14036-96-5 ]
Reference: [1] Journal of the American Chemical Society, 2015, vol. 137, # 2, p. 592 - 595
[2] Bioorganic and Medicinal Chemistry Letters, 2018, vol. 28, # 14, p. 2358 - 2363
  • 13
  • [ 5263-87-6 ]
  • [ 187679-62-5 ]
Reference: [1] Journal of the Chemical Society - Perkin Transactions 1, 1997, # 7, p. 1017 - 1024
  • 14
  • [ 5263-87-6 ]
  • [ 327044-56-4 ]
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2006, vol. 16, # 13, p. 3415 - 3418
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 5263-87-6 ]

Ethers

Chemical Structure| 1078-28-0

[ 1078-28-0 ]

6-Methoxy-2-methylquinoline

Similarity: 0.95

Chemical Structure| 783-08-4

[ 783-08-4 ]

N-Benzylidene-4-methoxyaniline

Similarity: 0.88

Chemical Structure| 52057-98-4

[ 52057-98-4 ]

6-(4-Methoxyphenyl)pyridin-3-amine

Similarity: 0.87

Chemical Structure| 14446-31-2

[ 14446-31-2 ]

6-Methoxy-3-methylisoquinoline

Similarity: 0.87

Chemical Structure| 4964-76-5

[ 4964-76-5 ]

7-Methoxyquinoline

Similarity: 0.85

Related Parent Nucleus of
[ 5263-87-6 ]

Quinolines

Chemical Structure| 1078-28-0

[ 1078-28-0 ]

6-Methoxy-2-methylquinoline

Similarity: 0.95

Chemical Structure| 4964-76-5

[ 4964-76-5 ]

7-Methoxyquinoline

Similarity: 0.85

Chemical Structure| 23432-40-8

[ 23432-40-8 ]

6-Methylquinolin-4-ol

Similarity: 0.85

Chemical Structure| 4363-94-4

[ 4363-94-4 ]

6-Methoxyquinoline-4-carbaldehyde

Similarity: 0.85

Chemical Structure| 87199-83-5

[ 87199-83-5 ]

7-Methoxyquinolin-3-amine

Similarity: 0.83